FR2393309A1 - Feces artificielles - Google Patents

Feces artificielles

Info

Publication number
FR2393309A1
FR2393309A1 FR7816092A FR7816092A FR2393309A1 FR 2393309 A1 FR2393309 A1 FR 2393309A1 FR 7816092 A FR7816092 A FR 7816092A FR 7816092 A FR7816092 A FR 7816092A FR 2393309 A1 FR2393309 A1 FR 2393309A1
Authority
FR
France
Prior art keywords
acid
detection
water
sparingly soluble
faeces
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7816092A
Other languages
English (en)
French (fr)
Other versions
FR2393309B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roehm GmbH Darmstadt
Original Assignee
Roehm GmbH Darmstadt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772724438 external-priority patent/DE2724438C2/de
Application filed by Roehm GmbH Darmstadt filed Critical Roehm GmbH Darmstadt
Publication of FR2393309A1 publication Critical patent/FR2393309A1/fr
Application granted granted Critical
Publication of FR2393309B1 publication Critical patent/FR2393309B1/fr
Granted legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664Blood serum or blood plasma standard or control

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR7816092A 1977-05-31 1978-05-30 Feces artificielles Granted FR2393309A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19772724438 DE2724438C2 (de) 1977-05-31 1977-05-31 Künstlicher Stuhl zu diagnostischen Zwecken
DE2819284A DE2819284C2 (de) 1977-05-31 1978-05-02 Künstlicher Stuhl zu diagnostischen Zwecken

Publications (2)

Publication Number Publication Date
FR2393309A1 true FR2393309A1 (fr) 1978-12-29
FR2393309B1 FR2393309B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-12-31

Family

ID=25772079

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7816092A Granted FR2393309A1 (fr) 1977-05-31 1978-05-30 Feces artificielles

Country Status (10)

Country Link
US (1) US4394452A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5417794A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT360660B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1119922A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH636965A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2819284C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2393309A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1579102A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1203184B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE443239B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3827561C1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1988-08-13 1989-12-28 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
US5385844A (en) * 1993-04-22 1995-01-31 Boehringer Mannheim Corporation Polymer containing control reagents and polymers useful in control reagents
WO1994029385A1 (en) * 1993-06-10 1994-12-22 The Procter & Gamble Company Synthetic fecal material
US5890907A (en) * 1997-01-13 1999-04-06 Clifford W. Estes Company, Inc. Educational doll
BR0213121A (pt) * 2001-10-05 2006-05-23 Steris Inc modelo in vitro para atividade priocidal
US6933152B1 (en) * 2003-04-04 2005-08-23 Nerl Diagnostics Artificial human feces
JP4544201B2 (ja) * 2006-05-26 2010-09-15 パナソニック電工株式会社 模擬便
JP4544200B2 (ja) * 2006-05-26 2010-09-15 パナソニック電工株式会社 模擬便
US20130052624A1 (en) * 2011-08-25 2013-02-28 Miguel Saps Tridimensional stool assessment instrument, methods, and uses thereof
JP5957641B2 (ja) * 2012-08-25 2016-07-27 彰 三池 擬似便組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1600599A (en) * 1926-03-29 1926-09-21 Parker Maria Louisa Model of the large intestine
GB432571A (en) * 1934-01-30 1935-07-30 Crosse & Blackwell Ltd Improvements in and relating to sealing compositions for cans, jars and other containers
US2320098A (en) * 1939-10-18 1943-05-25 Quisling Sverre Cosmetic coloring composition
US2699401A (en) * 1949-11-17 1955-01-11 Reardon Company Texture paint
GB708996A (en) * 1954-04-15 1954-05-12 Miles Lab Improvements in or relating to diagnostic compositions
US2925365A (en) * 1957-11-27 1960-02-16 Smith Kline French Lab Coloring solid pharmaceutical forms and compositions therefor
US3427176A (en) * 1962-11-28 1969-02-11 Shikoku Chem Three-dimensional coloring composition
US3933594A (en) * 1974-08-16 1976-01-20 Polaroid Corporation Method and device for determining the concentration of a substance in a fluid

Also Published As

Publication number Publication date
CH636965A5 (de) 1983-06-30
JPS5417794A (en) 1979-02-09
IT1203184B (it) 1989-02-15
IT7868238A0 (it) 1978-05-30
DE2819284C2 (de) 1985-12-19
US4394452A (en) 1983-07-19
JPS6236180B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-08-05
AT360660B (de) 1981-01-26
GB1579102A (en) 1980-11-12
DE2819284A1 (de) 1979-11-15
ATA351578A (de) 1980-06-15
CA1119922A (en) 1982-03-16
SE7806291L (sv) 1978-12-01
FR2393309B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-12-31
SE443239B (sv) 1986-02-17

Similar Documents

Publication Publication Date Title
FR2393309A1 (fr) Feces artificielles
ATE18251T1 (de) Verdickte waesserige netzmittelzubereitungen und ihre herstellung.
ES536909A0 (es) Procedimiento para la preparacion de compuestos complejos de piroxicam con ciclodestrinas
FI972580A0 (fi) Valmisteita ja menetelmiä ihoärsytyksen vähentämiseksi
ATE79748T1 (de) Viruzides mittel mit breitbandwirkung.
FR824389A (fr) Pompe pour introduire des médicaments dans le vagin ou l'anus et enveloppes contenant ces médicaments
FR2393566A1 (fr) Composition pour ostomie
KR960010010A (ko) 신규생리활성물질
Diesch et al. Isolation of pathogenic leptospires from waters used for recreation
BE904976A (fr) Formes de presentation solides,aptes a la conservation revetues d'une pellicule elastique.
TR199701012T1 (xx) Fungisidal kompozisyon.
ATE99924T1 (de) Amphipatische emulgiermittel enthaltende emulsionzusammensetzungen.
Blair Bilharziasis survey in British West and East Africa, Nyasaland, and the Rhodesias
FR2396548A1 (fr) Composition contenant du dithranol pour le traitement du psoriasis
MX9405740A (es) Composicion de cementacion para pozos de petroleo.
Romer Pharmacological evaluation of mild analgesics.
KR840005667A (ko) 진 단 장 치
BR9305503A (pt) Composição de betume/polímero vulcanizável a temperaturas inferiores a 100°C, sua preparação e sua utilização
NO882634L (no) Fremgangsmaate for aa oeke viskositeten til oljer.
SENEKJIE The clinical manifestations of leptospirosis in Louisiana
ATE9958T1 (de) 2-aryl-1,3-indandion-derivate und diese enthaltende mittel zur bekaempfung ektoparasitaerer akarina.
Shapiro et al. Toxicity studies on selenium disulfide suspension
Gordon Aramaic Incantation Bowls (Concluded)
Ouaissi et al. Occurrence of fibronectin antigenic determinants on Schistosoma mansoni lung schistosomula and adult worms
BE893025A (fr) Derives de l'acide 1,4-thiazane-carboxilique leurs preparation et utilisation ainsi que les compositions contenant ces derives.

Legal Events

Date Code Title Description
ST Notification of lapse